Cinese International Group Holdings Ltd
HKEX:1620
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cinese International Group Holdings Ltd
HKEX:1620
|
CA |
|
G
|
GORE German Office Real Estate AG
XETRA:GAG
|
DE |
|
Y
|
Yatharth Hospital & Trauma Care Services Ltd
NSE:YATHARTH
|
IN |
|
SK Target Group Ltd
HKEX:8427
|
MY |
|
V
|
Vizsla Silver Corp
AMEX:VZLA
|
CA |
|
S
|
Sime Darby Plantation Bhd
KLSE:SIMEPLT
|
MY |
|
Besunyen Holdings Co Ltd
HKEX:926
|
CN |
|
C
|
China Zhenhua Group Science & Technology Co Ltd
SZSE:000733
|
CN |
|
A
|
Al-Razi Medical Company SJSC
SAU:9572
|
SA |
|
C
|
CHTC Helon Co Ltd
SZSE:000677
|
CN |
|
Realord Group Holdings Ltd
HKEX:1196
|
HK |
Balance Sheet
Balance Sheet Decomposition
Cinese International Group Holdings Ltd
Cinese International Group Holdings Ltd
Balance Sheet
Cinese International Group Holdings Ltd
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
49
|
71
|
65
|
138
|
72
|
30
|
49
|
44
|
26
|
30
|
4
|
|
| Cash Equivalents |
49
|
71
|
65
|
138
|
72
|
30
|
49
|
44
|
26
|
30
|
4
|
|
| Short-Term Investments |
0
|
0
|
1
|
0
|
15
|
6
|
0
|
1
|
0
|
1
|
11
|
|
| Total Receivables |
22
|
25
|
28
|
85
|
109
|
51
|
37
|
36
|
78
|
59
|
25
|
|
| Accounts Receivables |
21
|
25
|
28
|
16
|
16
|
4
|
11
|
2
|
33
|
44
|
25
|
|
| Other Receivables |
1
|
0
|
0
|
69
|
94
|
47
|
26
|
33
|
45
|
15
|
0
|
|
| Other Current Assets |
12
|
63
|
86
|
5
|
5
|
4
|
4
|
3
|
3
|
4
|
4
|
|
| Total Current Assets |
83
|
159
|
182
|
228
|
202
|
92
|
90
|
84
|
107
|
95
|
44
|
|
| PP&E Net |
2
|
2
|
5
|
6
|
13
|
8
|
7
|
4
|
3
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
6
|
13
|
8
|
7
|
4
|
3
|
2
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
7
|
10
|
13
|
15
|
10
|
11
|
7
|
0
|
|
| Intangible Assets |
0
|
2
|
4
|
5
|
5
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
0
|
12
|
15
|
16
|
14
|
3
|
3
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
7
|
18
|
18
|
22
|
43
|
42
|
28
|
12
|
0
|
|
| Total Assets |
87
N/A
|
165
+90%
|
197
+20%
|
269
+36%
|
253
-6%
|
139
-45%
|
155
+11%
|
133
-14%
|
142
+7%
|
111
-22%
|
47
-57%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
11
|
0
|
15
|
29
|
24
|
|
| Accrued Liabilities |
54
|
77
|
95
|
7
|
6
|
3
|
8
|
5
|
8
|
9
|
5
|
|
| Short-Term Debt |
62
|
51
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
37
|
0
|
3
|
2
|
1
|
2
|
3
|
2
|
1
|
|
| Other Current Liabilities |
5
|
10
|
0
|
100
|
71
|
14
|
62
|
72
|
61
|
68
|
6
|
|
| Total Current Liabilities |
122
|
137
|
132
|
108
|
79
|
19
|
83
|
80
|
87
|
108
|
35
|
|
| Long-Term Debt |
0
|
29
|
0
|
0
|
5
|
6
|
7
|
6
|
4
|
2
|
1
|
|
| Deferred Income Tax |
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
122
N/A
|
167
+37%
|
133
-20%
|
108
-18%
|
85
-21%
|
26
-70%
|
91
+255%
|
85
-6%
|
92
+8%
|
110
+20%
|
36
-67%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
47
|
12
|
55
|
67
|
72
|
17
|
32
|
46
|
43
|
88
|
77
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
88
|
88
|
88
|
88
|
88
|
88
|
88
|
88
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
2
|
2
|
2
|
|
| Other Equity |
12
|
10
|
9
|
6
|
8
|
8
|
9
|
5
|
7
|
1
|
1
|
|
| Total Equity |
35
N/A
|
2
+95%
|
65
N/A
|
161
+149%
|
167
+4%
|
114
-32%
|
65
-43%
|
48
-26%
|
50
+5%
|
1
-99%
|
11
+1 935%
|
|
| Total Liabilities & Equity |
87
N/A
|
165
+90%
|
197
+20%
|
269
+36%
|
253
-6%
|
139
-45%
|
155
+11%
|
133
-14%
|
142
+7%
|
111
-22%
|
47
-57%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
900
|
900
|
900
|
1 200
|
1 200
|
1 200
|
1 200
|
1 200
|
1 200
|
1 200
|
1 200
|
|